These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33649198)

  • 21. Persistent methicillin-resistant Staphylococcus aureus bacteremia owing to placental abscess.
    Maeda N; Hagiya H; Takiuchi T; Kusakabe S; Maeda T; Kimura K; Iwai S; Kawasaki K; Hori Y; Morii E; Kanakura Y; Kimura T; Tomono K
    J Infect Chemother; 2018 Dec; 24(12):975-979. PubMed ID: 29804839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.
    Seidl K; Bayer AS; Fowler VG; McKinnell JA; Abdel Hady W; Sakoulas G; Yeaman MR; Xiong YQ
    Antimicrob Agents Chemother; 2011 Feb; 55(2):575-82. PubMed ID: 21098242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
    Honda H; Doern CD; Michael-Dunne W; Warren DK
    BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
    Burnett YJ; Echevarria K; Traugott KA
    Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
    Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia].
    Kagami K; Imai S; Tazawa Y; Iwasaki S; Fukumoto T; Akizawa K; Yamada T; Ishiguro N; Iseki K
    Yakugaku Zasshi; 2018; 138(9):1181-1189. PubMed ID: 30175762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
    Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
    JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.
    Ok HS; Lee HS; Park MJ; Kim KH; Kim BK; Wi YM; Kim JM
    Korean J Intern Med; 2013 Nov; 28(6):678-86. PubMed ID: 24307843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus Causing Bloodstream Infections at Ruijin Hospital in Shanghai from 2013 to 2018.
    Gu F; He W; Xiao S; Wang S; Li X; Zeng Q; Ni Y; Han L
    Sci Rep; 2020 Apr; 10(1):6019. PubMed ID: 32265473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.
    Welsh KJ; Abbott AN; Lewis EM; Gardiner JM; Kruzel MC; Lewis CT; Mohr JF; Wanger A; Armitige LY
    J Clin Microbiol; 2010 Mar; 48(3):894-9. PubMed ID: 20089758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Molecular Characteristics of
    Hong SI; Lee YM; Park KH; Ryu BH; Hong KW; Kim S; Bae IG; Cho OH
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Community-Onset Methicillin-Resistant
    Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN
    Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
    Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
    Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.